Scientific article

Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis

Published inJournal of neuroimmunology, vol. 285, p. 1-3
Publication date2015

Neurosarcoidosis (NS) is a rare condition that may mimic central nervous system (CNS) infection, neoplasia and other inflammatory disorders of the CNS such as multiple sclerosis, encephalitis and vasculitis. Diagnosis is challenging in cases with minimal or absent systemic involvement. Cerebrospinal fluid (CSF) angiotensin-converting enzyme (c-ACE) has been claimed as a valuable diagnostic tool for NS. However, there is little data evaluating its performance in routine clinical practice.

  • Adult
  • Aged
  • Biological Markers/cerebrospinal fluid
  • Central Nervous System Diseases/cerebrospinal fluid/diagnosis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A/cerebrospinal fluid
  • Retrospective Studies
  • Sarcoidosis/cerebrospinal fluid/diagnosis
Citation (ISO format)
BRIDEL, Claire et al. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis. In: Journal of neuroimmunology, 2015, vol. 285, p. 1–3. doi: 10.1016/j.jneuroim.2015.05.020
Main files (1)
Article (Published version)
ISSN of the journal0165-5728

Technical informations

Creation11/05/2015 10:37:00 AM
First validation11/05/2015 10:37:00 AM
Update time03/15/2023 12:10:28 AM
Status update03/15/2023 12:10:28 AM
Last indexation10/19/2023 12:49:11 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack